Eversept Partners, LP Amarin Corp Plcuk Transaction History

Eversept Partners, LP

  • $993 Million
  • Q2 2025

Shares

47 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2025

May 15, 2025
BUY
$0.4 - $8.96 $753,044 - $16.9 Million
1,882,612 Added 124.13%
3,399,204 $30.5 Million
Q4 2024

Feb 14, 2025
SELL
$0.44 - $0.63 $788,795 - $1.13 Million
-1,792,717 Reduced 54.17%
1,516,592 $727,000
Q3 2024

Nov 14, 2024
SELL
$0.57 - $0.8 $569,554 - $799,374
-999,218 Reduced 23.19%
3,309,309 $2.08 Million
Q2 2024

Aug 14, 2024
SELL
$0.63 - $1.07 $1.2 Million - $2.04 Million
-1,904,221 Reduced 30.65%
4,308,527 $2.97 Million
Q1 2024

May 15, 2024
BUY
$0.82 - $1.35 $96,139 - $158,278
117,243 Added 1.92%
6,212,748 $5.53 Million
Q4 2023

Feb 14, 2024
SELL
$0.66 - $0.91 $1.54 Million - $2.13 Million
-2,336,370 Reduced 27.71%
6,095,505 $5.3 Million
Q3 2023

Nov 14, 2023
SELL
$0.85 - $1.43 $1.76 Million - $2.96 Million
-2,070,234 Reduced 19.71%
8,431,875 $7.76 Million
Q2 2023

Nov 08, 2023
SELL
$1.12 - $1.49 $1.64 Million - $2.18 Million
-1,460,635 Reduced 12.21%
10,502,109 $12.5 Million
Q2 2023

Aug 14, 2023
BUY
$1.12 - $1.49 $11.8 Million - $15.6 Million
10,502,109 New
10,502,109 $12.5 Million
Q3 2022

Nov 08, 2023
SELL
$1.09 - $1.67 $1.44 Million - $2.21 Million
-1,322,150 Reduced 9.95%
11,962,744 $13 Million
Q3 2022

Nov 14, 2022
SELL
$1.09 - $1.67 $1.44 Million - $2.21 Million
-1,322,150 Reduced 9.95%
11,962,744 $13 Million
Q2 2022

Nov 08, 2023
BUY
$1.13 - $3.69 $4.86 Million - $15.9 Million
4,304,749 Added 47.94%
13,284,894 $19.8 Million
Q2 2022

Aug 15, 2022
BUY
$1.13 - $3.69 $4.86 Million - $15.9 Million
4,304,749 Added 47.94%
13,284,894 $19.8 Million
Q1 2022

Nov 08, 2023
SELL
$2.85 - $3.73 $4.34 Million - $5.68 Million
-1,521,964 Reduced 14.49%
8,980,145 $29.5 Million
Q1 2022

May 16, 2022
SELL
$2.85 - $3.73 $4.54 Million - $5.94 Million
-1,593,157 Reduced 15.07%
8,980,145 $29.5 Million
Q4 2021

Nov 08, 2023
SELL
$3.24 - $5.18 $3.34 Million - $5.34 Million
-1,031,688 Reduced 8.89%
10,573,302 $35.6 Million
Q4 2021

Feb 14, 2022
SELL
$3.24 - $5.18 $3.34 Million - $5.34 Million
-1,031,688 Reduced 8.89%
10,573,302 $35.6 Million
Q3 2021

Nov 08, 2023
SELL
$3.94 - $5.84 $20 Million - $29.6 Million
-5,064,481 Reduced 30.38%
11,604,990 $59.2 Million
Q3 2021

Nov 15, 2021
SELL
$3.94 - $5.84 $20 Million - $29.6 Million
-5,064,481 Reduced 30.38%
11,604,990 $59.2 Million
Q2 2021

Nov 08, 2023
SELL
$4.26 - $6.5 $968,404 - $1.48 Million
-227,325 Reduced 1.35%
16,669,471 $73 Million
Q2 2021

Aug 16, 2021
SELL
$4.26 - $6.5 $968,404 - $1.48 Million
-227,325 Reduced 1.35%
16,669,471 $73 Million
Q1 2021

Nov 08, 2023
BUY
$5.03 - $8.8 $4.79 Million - $8.39 Million
952,881 Added 5.98%
16,896,796 $105 Million
Q1 2021

May 13, 2021
BUY
$5.03 - $8.8 $4.79 Million - $8.39 Million
952,881 Added 5.98%
16,896,796 $105 Million
Q4 2020

Nov 08, 2023
BUY
$4.04 - $5.31 $22 Million - $28.9 Million
5,441,806 Added 51.82%
15,943,915 $78 Million
Q4 2020

Feb 16, 2021
BUY
$4.04 - $5.31 $21.4 Million - $28.1 Million
5,290,456 Added 49.66%
15,943,915 $78 Million
Q3 2020

Nov 08, 2023
BUY
$3.64 - $7.76 $21.4 Million - $45.5 Million
5,867,358 Added 122.59%
10,653,459 $44.9 Million
Q3 2020

Nov 13, 2020
BUY
$3.64 - $7.76 $21.4 Million - $45.5 Million
5,867,358 Added 122.59%
10,653,459 $44.9 Million
Q2 2020

Nov 08, 2023
BUY
$4.78 - $8.26 $6.13 Million - $10.6 Million
1,282,039 Added 36.59%
4,786,101 $33.1 Million
Q2 2020

Aug 13, 2020
BUY
$4.78 - $8.26 $6.13 Million - $10.6 Million
1,282,039 Added 36.59%
4,786,101 $33.1 Million
Q1 2020

Nov 08, 2023
BUY
$4.0 - $21.53 $10.4 Million - $55.7 Million
2,588,472 Added 282.71%
3,504,062 $14 Million
Q1 2020

May 13, 2020
BUY
$4.0 - $21.53 $10.4 Million - $55.7 Million
2,588,472 Added 282.71%
3,504,062 $14 Million
Q4 2019

Nov 08, 2023
SELL
$13.94 - $24.12 $5.77 Million - $9.99 Million
-414,105 Reduced 31.14%
915,590 $19.6 Million
Q4 2019

Feb 13, 2020
SELL
$13.94 - $24.12 $5.77 Million - $9.99 Million
-414,105 Reduced 31.14%
915,590 $19.6 Million
Q3 2019

Nov 08, 2023
SELL
$13.89 - $23.16 $3.17 Million - $5.29 Million
-228,370 Reduced 14.66%
1,329,695 $20.2 Million
Q3 2019

Nov 13, 2019
SELL
$13.89 - $23.16 $3.17 Million - $5.29 Million
-228,370 Reduced 14.66%
1,329,695 $20.2 Million
Q2 2019

Nov 08, 2023
SELL
$16.27 - $20.51 $8.17 Million - $10.3 Million
-502,222 Reduced 24.38%
1,558,065 $30.2 Million
Q2 2019

Aug 13, 2019
SELL
$16.27 - $20.51 $8.17 Million - $10.3 Million
-502,222 Reduced 24.38%
1,558,065 $30.2 Million
Q1 2019

Nov 08, 2023
BUY
$12.61 - $22.33 $10 Million - $17.8 Million
796,880 Added 63.07%
2,060,287 $42.8 Million
Q1 2019

May 14, 2019
BUY
$12.61 - $22.33 $10 Million - $17.8 Million
796,880 Added 63.07%
2,060,287 $42.8 Million
Q4 2018

Nov 08, 2023
BUY
$12.41 - $22.98 $3.32 Million - $6.15 Million
267,707 Added 26.89%
1,263,407 $17.2 Million
Q4 2018

Feb 13, 2019
BUY
$12.41 - $22.98 $3.32 Million - $6.15 Million
267,707 Added 26.89%
1,263,407 $17.2 Million
Q3 2018

Nov 08, 2023
BUY
$2.45 - $16.27 $1.31 Million - $8.72 Million
535,700 Added 116.46%
995,700 $16.2 Million
Q3 2018

Nov 14, 2018
BUY
$2.45 - $16.27 $1.31 Million - $8.72 Million
535,700 Added 116.46%
995,700 $16.2 Million
Q2 2018

Nov 08, 2023
BUY
$2.68 - $3.48 $562,800 - $730,800
210,000 Added 84.0%
460,000 $1.42 Million
Q2 2018

Aug 14, 2018
BUY
$2.68 - $3.48 $562,800 - $730,800
210,000 Added 84.0%
460,000 $1.42 Million
Q1 2018

Nov 08, 2023
SELL
$2.99 - $4.44 $30.7 Million - $45.5 Million
-10,252,109 Reduced 97.62%
250,000 $753 Million
Q1 2018

May 14, 2018
BUY
$2.99 - $4.44 $747,500 - $1.11 Million
250,000 New
250,000 $753,000

Others Institutions Holding AMRN

# of Institutions
32
Shares Held
3.85M
Call Options Held
0
Put Options Held
0
View Full List

About AMARIN CORP PLCUK

AMRN Quotes by TradingView
  • Ticker AMRN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 403,206,016
  • Market Cap $6.01B
  • Description
  • Amarin Corporation plc, a pharmaceutical company, engages in the development and commercialization of therapeutics for the treatment of cardiovascular diseases in the United States, Germany, Canada, Lebanon, and the United Arab Emirates. Its lead product is VASCEPA, a prescription-only omega-3 fatty acid product, used as an adjunct to diet for r...
More about AMRN
Track This Portfolio

Track Eversept Partners, LP Portfolio

Follow Eversept Partners, LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Eversept Partners, LP, based on Form 13F filings with the SEC.

News

Stay updated on Eversept Partners, LP with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email